stockportfolio.pro
Sotera Health Company P/E Ratio 2019–2025
Sotera Health Company (SHC) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +2.2%/yr over 6 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 65.33 | -23.6% |
| FY 2024 | 85.50 | -8.7% |
| FY 2023 | 93.61 | — |
| FY 2022 | — | — |
| FY 2021 | 57.44 | — |
| FY 2020 | — | — |
| FY 2019 | — | — |
Source: Sotera Health Company SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Sotera Health Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSotera Health Company — frequently asked questions
What is Sotera Health Company's price-to-earnings ratio?
Sotera Health Company (SHC) reported price-to-earnings ratio of 65.33 for fiscal year 2025, per its SEC filings.
How has Sotera Health Company's price-to-earnings ratio changed over time?
Between fiscal 2019 and 2025, SHC's price-to-earnings ratio grew at roughly 2.2% per year (compound annual rate), from 57.44 to 65.33.
Where does this data come from?
Figures are computed from Sotera Health Company's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.